Sökresultat

Filtyp

Din sökning på "*" gav 540473 sökträffar

Changes and information due to Covid-19 (Corona)

Lund University is following the Government and Public Health Authority’s recommendations regarding measures to reduce the spread of the coronavirus and has therefore decided that education and examinations should be conducted using online alternatives (distance education) from 18 March. On this page we have gathered some useful information on how this affects opening hours, teaching and so on.  N

https://www.ace.lu.se/article/changes-and-information-due-covid-19-corona - 2025-10-01

How China has handled the crises

Interview with Marina Svensson, Professor of Modern China Studies here at the Centre. The Corona-crisis has started discussions on Chinese social media that have been quiet for a long time. Voices are now demanding freedom of the press, and the doctor exposing the virus to the world has been called a whistle-blower. This says Marina Svensson, Professor and Director at the Centre for East and South

https://www.ace.lu.se/article/how-china-has-handled-crises - 2025-10-01

Applications open for 2 postdoctoral fellowships

Applications are now open for 2 postdoctoral fellowships in China’s, Japan’s, and/or Korea’s contemporary society at the Centre for East and South-East Asian Studies, Lund University. Starting date 1 October 2020, or by agreement. DutiesThe person employed is expected to work independently but should also cooperate with other researchers at the Centre. The postdoctoral fellow should participate in

https://www.ace.lu.se/article/applications-open-2-postdoctoral-fellowships - 2025-10-01

New publication on heritage in China

Marina Svensson has published a chapter in the volume The Heritage Turn in China: The Reinvention, Dissemination and Consumption of Heritage Marina Svensson has published a chapter in the volume The Heritage Turn in China: The Reinvention, Dissemination and Consumption of Heritage (Amsterdam University Press) edited by Carol Ludwig, Linda Walton, and Yi-Wen Wang.The title of Marina's chapter is “L

https://www.ace.lu.se/article/new-publication-heritage-china - 2025-10-01

New publication on civil society elites in Cambodia

Dr Astrid Norén-Nilsson has co-authored an article on civil society elites in Cambodia published in the journal Politics and Governance. The title of the article is "Pathways to Leadership within and beyond Cambodian Civil Society: Elite Status and Boundary-Crossing". It addresses elitisation in Cambodian civil society and how such processes relate to holding elite status in the state, electoral p

https://www.ace.lu.se/article/new-publication-civil-society-elites-cambodia - 2025-10-01

Is OA linked to cancer?

In a new Swedish study by Lund University on comorbidities in osteoarthritis, researchers studied if people with osteoarthritis are at an increased risk for cancer compared to people without osteoarthritis. The study focused on the four most common cancer types, lung, colon, breast, and prostate cancer. Researchers found no differences in the risk of being diagnosed with colon cancer if you had os

https://www.arthritisportal.lu.se/article/oa-linked-cancer - 2025-10-01

Your genes play a part in the development of OA and perceived joint pain

Previous studies from Iceland have shown how osteoarthritis is often inherited and can be traced back several generations. A gene (genetic predisposition) is a segment of DNA containing hereditary information and is inherited from our biological parents. A new international study published in the high-ranking scientific journal Cell has discovered that a large number of genes are associated with o

https://www.arthritisportal.lu.se/article/your-genes-play-part-development-oa-and-perceived-joint-pain - 2025-10-01

Devil's Claw - the herbal medicine with a continued uncertain effect on OA pain

Devil's Claw (Harpagophytum procumbens) is a plant in the sesame family native South Africa that has long been used as a herbal medicine to treat a number of different diseases. The plant is believed to be able to reduce joint pain and joint stiffness as it is said to have analgesic and anti-inflammatory properties. However, the actual properties of devil's claw are yet not fully understood. There

https://www.arthritisportal.lu.se/article/devils-claw-herbal-medicine-continued-uncertain-effect-oa-pain - 2025-10-01

The global burden of osteoarthritis

Osteoarthritis has been described as the 15th most common cause of so-called “years lived with disability” (YLDs) in the world, which is a measure used to shed light on the burden of various diseases on society. According to the researchers, the economic costs caused by the disease correspond to about 1-2.5% of the gross domestic product (GDP) in most countries. A new article from a group of Ameri

https://www.arthritisportal.lu.se/article/global-burden-osteoarthritis - 2025-10-01

Common comorbidities in osteoarthritis

In a new Swedish study by Lund University, researchers looked at how common it is with comorbidities in osteoarthritis of the knee and/or hip. The study was published in the American journal Arthritis Care & Research. The study analyzed data collected from the province of Scania's population between the years 1998 and 2017. Newly diagnosed osteoarthritis patients were at a slightly higher risk of

https://www.arthritisportal.lu.se/article/common-comorbidities-osteoarthritis - 2025-10-01

The effect of PRP on ankle OA: No better than placebo

Earlier in October, we reported on a research study that showed that platelet-rich plasma (PRP) injections for treating osteoarthritis of the knee did not have a better effect on OA symptoms than placebo. Last week, results from a new study on PRP were published. The researchers concluded that PRP injections had no effect on ankle OA compared to placebo. The Dutch study included 100 ankle OA patie

https://www.arthritisportal.lu.se/article/effect-prp-ankle-oa-no-better-placebo - 2025-10-01

Not approved in the EU: Another setback for the drug tanezumab

The painkiller tanezumab was not approved by the European Medicine's Agency. At the beginning of 2021, news came that tanezumab, a new pain medication, would be launched in the US and Europe.  However, in March, tanezumab suffered a setback in the United States when the US Food and Drug Administration rejected the drug for osteoarthritis pain. There was continued uncertainty about the launch of th

https://www.arthritisportal.lu.se/article/not-approved-eu-another-setback-drug-tanezumab - 2025-10-01

The many risks of the painkiller tramadol

Tramadol is an increasingly common drug prescribed for pain. Tramadol is a synthetic opioid (manufactured in a lab) that differs somewhat in its chemical structure compared to the natural opioid codeine. Other opioids include morphine and heroin. All opioids have analgesic properties and are extremely addictive. In a new study based on primary care data from Spain, the risks of a number of side ef

https://www.arthritisportal.lu.se/article/many-risks-painkiller-tramadol - 2025-10-01

The benefits and side effects of common pain meds for osteoarthritis of the knee and hip

In a new meta-analysis (a compilation of results from a number of different research studies), the benefits and side effects of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), paracetamol, and opioids have been studied. The research study included data from 181 publications describing 192 clinical trials involving a total of over 100,000 patients. The researchers found that the NSAID etoricoxib (6

https://www.arthritisportal.lu.se/article/benefits-and-side-effects-common-pain-meds-osteoarthritis-knee-and-hip - 2025-10-01

How common is knee osteoarthritis?

A Chinese research group has compiled data from 88 different scientific studies on the prevalence of knee osteoarthritis. The studies were from all around the world and together included more than 10 million people. The researchers estimated that for individuals aged 40 years and older, the global prevalence of knee osteoarthritis is around 23%. This means that almost every fourth person over the

https://www.arthritisportal.lu.se/article/how-common-knee-osteoarthritis - 2025-10-01

PRP injections no more effective than placebo

PRP treatment (platelet-rich plasma) is a relatively new experimental treatment that is often marketed to be effective for patients with osteoarthritis. However, there is a lack of high-quality research claiming the effectiveness of the treatment. Researchers from Brazil have recently published results from a small clinical trial (including 61 patients) evaluating three different treatments. The p

https://www.arthritisportal.lu.se/article/prp-injections-no-more-effective-placebo - 2025-10-01

Osteoarthritis roundtable: Best from the ACR conference 2021

Doctors Jack Cush, Martin Englund, Gillian Hawker, Tihuna Neogi, and Kent Kwoh discuss the best OA research from the 2021 ACR (American College of Rheumatology) conference, including a new study indicating that the diabetes medicine metformin lowers the risk of developing osteoarthritis. Dr. Jack Cush is a professor of internal medicine at The University of Texas Southwestern Medical School, in th

https://www.arthritisportal.lu.se/article/osteoarthritis-roundtable-best-acr-conference-2021 - 2025-10-01

Increased burden by osteoarthritis in the world

In a recent study, a group of scientists have evaluated the burden of osteoarthritis over the past three decades, using data from the worldwide initiative ”Global Burden of Disease study 2019.  The results show that the number of people affected by osteoarthritis has increased by about 113 percent in 30 years, from about 248 million in year 1990 to about 530 million in year 2019. The authors concl

https://www.arthritisportal.lu.se/article/increased-burden-osteoarthritis-world - 2025-10-01

Is there a link between OA and obesity?

Researchers from Australia have investigated the incidence of obesity in patients with OA undergoing knee replacement. In a recent study from Australia researchers have investigated the incidence of obesity in patients undergoing knee replacements because of their OA. The results were compared to the incidence of obesity in the general population. The results show that of the 56 000 patients who u

https://www.arthritisportal.lu.se/article/there-link-between-oa-and-obesity - 2025-10-01

Frequent use of strong painkillers in patients with knee osteoarthritis the years before total knee replacement

Researchers have investigated the use of strong painkillers the years prior total knee replacement. A recent study from England and Sweden (Lund University) has investigated the number of patients with knee osteoarthritis having required treatment with opioids in the years prior to total knee replacement. Opioids are a group of strong painkillers including Morphine, Oxycodone, Tramadol and Citodon

https://www.arthritisportal.lu.se/article/frequent-use-strong-painkillers-patients-knee-osteoarthritis-years-total-knee-replacement - 2025-10-01